s6y
Company name or ticker
Search
Addex Therapeutics Ltd.
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Filed
Wednesday, July 8, 2026
Period
Jul 8, 2026
Accession number
0001171843-26-004524
Documents
FORM 6-K
6-K
PRESS RELEASE
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header